×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Entera Bio Ltd. (ENTX) NASDAQ

$1.67 0.13 (8.44%)

Market Cap: $54.64M

As of 03/28/24 04:00 PM EDT. Market closed.

(ENTX)

Entera Bio Ltd. (ENTX)
NASDAQ

$1.67
0.13 (8.44%)

Market Cap: $54.64M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

entera bio ltd. is a biotechnology company located in ... read more

entera bio ltd. is a biotechnology company located in israel. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Adam Gridley
Full Time Employees
15
URL
Address
Kiryat Hadassah, Minrav Building, Jerusalem, Fifth Floor, 9112002.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Adam Gridley
Full Time Employees
15
Address
Kiryat Hadassah, Minrav Building, Jerusalem, Fifth Floor, 9112002.
PRICE CHART FOR ENTERA BIO LTD
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.59
Previous Close
$1.54
Days Range
$1.53 - $1.64
52 week range
$0.52 - $1.87
Volume
124,886
Avg. Volume (30 days)
233,846
Market Cap
$54.64M
Dividend Yield
-
P/E
-
Shares Outstanding
35,481,341
Open
$1.59
Previous Close
$1.54
Days Range
$1.53 - $1.64
52 week range
$0.52 - $1.87
Volume
124,886
Avg. Volume (30 days)
233,846
Market Cap
$54.64M
Dividend Yield
-
P/E
-
Shares Outstanding
35,481,341
FINANCIAL STATEMENTS FOR ENTERA BIO LTD
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ENTERA BIO LTD
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Taitel HayaDirectorJan 12, 2024 Buy$0.999,5009,40535,115Jan 16, 2024, 08:00 AM
Taitel HayaDirectorJan 10, 2024 Buy$0.777,6155,86425,615Jan 11, 2024, 06:14 PM
LIEBERMAN GERALD MDirectorDec 22, 2023 Buy$0.7123,95217,006226,961Dec 27, 2023, 05:00 PM
Toledano Miranda JayneChief Executive OfficerDec 22, 2023 Buy$0.7123,95217,006110,752Dec 27, 2023, 08:27 AM
Taitel HayaDirectorAug 22, 2023 Buy$0.6218,00011,21618,000Aug 24, 2023, 08:12 AM
LIEBERMAN GERALD MDirectorAug 21, 2023 Buy$0.5920,00011,784214,209Aug 23, 2023, 09:28 AM
Ellis SeanDirectorAug 21, 2023 Buy$0.6040,00024,000102,100Aug 22, 2023, 09:20 AM
Toledano Miranda JayneChief Executive OfficerApr 04, 2023 Buy$1.0130,00030,30086,800Apr 06, 2023, 04:05 PM
Yaacov-Garbeli DanaChief Financial OfficerNov 14, 2022 Buy$0.5426,58014,24756,580Nov 15, 2022, 04:13 PM
Yaacov-Garbeli DanaChief Financial OfficerNov 11, 2022 Buy$0.5230,00015,60030,000Nov 15, 2022, 04:13 PM
LIEBERMAN GERALD MDirectorNov 14, 2022 Buy$0.5716,0009,0806,200Nov 15, 2022, 04:07 PM
LIEBERMAN GERALD MDirectorNov 14, 2022 Buy$0.5734,00019,380194,209Nov 15, 2022, 04:07 PM
Ellis SeanDirectorNov 11, 2022 Buy$0.5330,00015,90062,100Nov 14, 2022, 09:17 AM
Toledano Miranda JayneChief Executive OfficerNov 11, 2022 Buy$0.5350,00026,58556,800Nov 14, 2022, 09:13 AM
Ellis SeanDirectorJul 21, 2022 Buy$1.6414,90024,40632,100Jul 25, 2022, 05:19 PM
LIEBERMAN GERALD MDirectorJul 21, 2022 Buy$1.6819,49132,803160,209Jul 25, 2022, 05:16 PM
OSTROV GERALD MDirectorJan 13, 2022 Buy$2.7410,00027,37810,000Jan 25, 2022, 08:46 AM
Ratan RameshU.S.based CFOJan 19, 2022 Buy$2.4410,00024,36410,000Jan 24, 2022, 04:21 PM
JAMAS SPIROSChief Executive OfficerJan 18, 2022 Buy$2.8510,00028,50010,000Jan 24, 2022, 04:19 PM
Schwartz PhillipPresident of R&DJan 20, 2022 Buy$2.5310,00025,250607,410Jan 24, 2022, 04:17 PM
LIEBERMAN GERALD MDirectorJan 18, 2022 Buy$2.802,8007,8402,200Jan 24, 2022, 04:15 PM
Mayron RonDirectorJan 18, 2022 Buy$2.807,00019,6007,000Jan 19, 2022, 04:07 PM
Toledano Miranda JayneDirectorJan 14, 2022 Buy$2.796,80018,9716,800Jan 19, 2022, 04:04 PM
Ellis SeanDirectorJan 18, 2022 Buy$2.8110,00028,05010,000Jan 19, 2022, 04:02 PM
Malca YonatanDirectorJan 13, 2022 Buy$2.747,23219,8167,232Jan 18, 2022, 04:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Taitel HayaDirector01/12/20249,405
Taitel HayaDirector01/10/20245,864
LIEBERMAN GERALD MDirector12/22/202317,006
Toledano Miranda JayneChief Executive Officer12/22/202317,006
Taitel HayaDirector08/22/202311,216
LIEBERMAN GERALD MDirector08/21/202311,784
Ellis SeanDirector08/21/202324,000
Toledano Miranda JayneChief Executive Officer04/04/202330,300
Yaacov-Garbeli DanaChief Financial Officer11/14/202214,247
Yaacov-Garbeli DanaChief Financial Officer11/11/202215,600
LIEBERMAN GERALD MDirector11/14/20229,080
LIEBERMAN GERALD MDirector11/14/202219,380
Ellis SeanDirector11/11/202215,900
Toledano Miranda JayneChief Executive Officer11/11/202226,585
Ellis SeanDirector07/21/202224,406
LIEBERMAN GERALD MDirector07/21/202232,803
OSTROV GERALD MDirector01/13/202227,378
Ratan RameshU.S.based CFO01/19/202224,364
JAMAS SPIROSChief Executive Officer01/18/202228,500
Schwartz PhillipPresident of R&D01/20/202225,250
LIEBERMAN GERALD MDirector01/18/20227,840
Mayron RonDirector01/18/202219,600
Toledano Miranda JayneDirector01/14/202218,971
Ellis SeanDirector01/18/202228,050
Malca YonatanDirector01/13/202219,816
Load More Insider Transactions
FUNDS WITH A POSITION IN ENTERA BIO LTD
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC57,4000.00005%145.3%Other
GEODE CAPITAL MANAGEMENT, LLC17,5970%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ENTERA BIO LTD
STOCK BUYBACKS FOR ENTERA BIO LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.71%
1Q
12/31/2023
06/30/2023
2.72%
2Q
12/31/2023
03/31/2023
2.72%
3Q
12/31/2023
12/31/2022
2.72%
4Q
12/31/2023
09/30/2022
2.72%
5Q
12/31/2023
06/30/2022
2.73%
6Q
12/31/2023
03/31/2022
2.74%
7Q
12/31/2023
12/31/2021
2.31%
8Q
12/31/2023
09/30/2021
3.19%
9Q
12/31/2023
06/30/2021
19.74%
10Q
12/31/2023
03/31/2021
35.20%
11Q
12/31/2023
12/31/2020
55.32%
12Q
12/31/2023
09/30/2020
61.46%
13Q
12/31/2023
06/30/2020
62.30%
14Q
12/31/2023
03/31/2020
63.97%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.71%
1Q
06/30/2023
2.72%
2Q
03/31/2023
2.72%
3Q
12/31/2022
2.72%
4Q
09/30/2022
2.72%
5Q
06/30/2022
2.73%
6Q
03/31/2022
2.74%
7Q
12/31/2021
2.31%
8Q
09/30/2021
3.19%
9Q
06/30/2021
19.74%
10Q
03/31/2021
35.20%
11Q
12/31/2020
55.32%
12Q
09/30/2020
61.46%
13Q
06/30/2020
62.30%
14Q
03/31/2020
63.97%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ENTERA BIO LTD
LOADING...